交易中 04-01 10:43:32 美东时间
+0.890
+1.57%
今日重点评级关注:Oppenheimer:维持Alumis"跑赢大市"评级,目标价从50美元升至55美元;美银证券:维持Rocket Pharmaceuticals"买入"评级,目标价从8美元升至9美元
03-31 16:30
Baird analyst Robert Mason maintains Atmus Filtration Techs (NYSE:ATMU) with a Outperform and lowers the price target from $69 to $66.
03-30 21:07
Costco is the subject of a proposed nationwide class-action lawsuit demanding refunds for customers who were charged higher price.
03-12 16:43
The U.S. Court of International Trade in New York has ordered the government to refund potentially billions in tariffs to importers, stating that these tariffs were unlawfully collected.
03-05 15:17
今日重点评级关注:杰富瑞:上调BioAge Labs评级至"买入",目标价从9美元升至62美元;RBC Capital:维持COMPASS Pathways Plc Sponsored ADR"跑赢大市"评级,目标价从21美元升至22美元
02-19 16:21
今日重点评级关注:Ascendiant Capital:维持RenovoRx"买入"评级,目标价从12.5美元升至13美元;Lake Street:维持Insight Molecular"买入"评级,目标价从8美元升至12美元
02-18 16:48
Wells Fargo analyst Joseph O'Dea maintains Atmus Filtration Techs (NYSE:ATMU) with a Equal-Weight and raises the price target from $54 to $67.
02-17 22:21
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Atmus业绩会实录,以下是业绩回顾摘要: ## 1. 财务业绩 **第四季度业绩:** - 营收:4.47亿美元,同比增长9.8%,增长驱动因素包括5%的定价提升、4%的销量增长和1%的汇率正面影响 - 调整后EBITDA:8,500万美元,利润率19.1%,与去年同期持平 - 调整后每股收益:0.66美元,高于去年同期的0.58美元 - 调整后自由现金流:3,100万美元,同比增长 **全年业绩:** - 营收:17.64亿美元,同比增长5.7% - 毛利润:4.98亿美元,同比增长3,600万美元 - 调整后EBITDA:3.54亿美元,利
02-14 12:16
华盛资讯2月13日讯,Atmus Filtration Technologies, Inc.公布2025财年Q4业绩,公司Q4营收4.47亿美元,同比增长9.8%,归母净利润0.48亿美元,同比增长19.7%。
02-13 20:02
Atmus Filtration Techs (NYSE:ATMU) released its Q4 earnings on Friday, February...
02-13 19:46